Literature DB >> 3296963

Effect of orally administered aromatic retinoid on murine Langerhans cells.

T Shiohara, M Kobayashi, H Narimatsu, M Nagashima.   

Abstract

The effect of orally administered aromatic retinoid (Ro 10-9359) on murine epidermal Langerhans cells (LC) was studied in vivo and in vitro. Daily administration of retinoid caused a transient increase in LC density, as determined by staining for Ia antigens, during the first few days of treatment and thereafter a continuing decrease that reached a maximum at 2 weeks. In addition, the morphology and location in the epidermis had been altered. When the treatment was continued to 4 weeks, the density of LC returned to normal. The Ia-antigen-presenting function of epidermal cells to an allo-Ia-reactive cloned T cell line was elevated at all stages of retinoid treatment examined. This elevation did not correlate with the density of histochemically stainable Ia+ LC. These findings suggest that orally administered retinoid profoundly alters the functional capacity of Ia+ LC.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3296963     DOI: 10.1007/BF00413258

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  18 in total

1.  Quantitative variation in la antigen expression plays a central role in immune regulation.

Authors:  C A Janeway; K Bottomly; J Babich; P Conrad; S Conzen; B Jones; J Kaye; M Katz; L McVay; D B Murphy; J Tite
Journal:  Immunol Today       Date:  1984-04

2.  Therapeutic effects of an aromatic retinoic acid analog on chemically induced skin papillomas and carcinomas of mice.

Authors:  W Bollag
Journal:  Eur J Cancer       Date:  1974-11       Impact factor: 9.162

3.  The effects of ultraviolet light and certain drugs on La-bearing Langerhans cells in murine epidermis.

Authors:  J J Nordlund; A E Ackles; A B Lerner
Journal:  Cell Immunol       Date:  1981-05-01       Impact factor: 4.868

4.  Stimulatory effects of vitamin A analogs on induction of cell-mediated cytotoxicity in vivo.

Authors:  R Lotan; G Dennert
Journal:  Cancer Res       Date:  1979-01       Impact factor: 12.701

Review 5.  Retinoids, cancer, and the skin.

Authors:  P M Elias; M L Williams
Journal:  Arch Dermatol       Date:  1981-03

6.  Ultrastructural evidence suggesting an immunomodulatory activity of oral retinoid. Its effect on dermal components in psoriasis.

Authors:  D Tsambaos; C E Orfanos
Journal:  Br J Dermatol       Date:  1981-01       Impact factor: 9.302

Review 7.  Expression of Ia antigens on Langerhans cells in mice, guinea pigs, and man.

Authors:  G Rowden
Journal:  J Invest Dermatol       Date:  1980-07       Impact factor: 8.551

8.  The in vitro effect of retinol on human gingival epithelium. II. Modulation of Langerhans cell markers and interleukin-1 production.

Authors:  L J Walsh; G J Seymour; R N Powell
Journal:  J Invest Dermatol       Date:  1985-12       Impact factor: 8.551

9.  Epidermal Langerhans cell involvement in cutaneous lupus erythematosus.

Authors:  R D Sontheimer; P R Bergstresser
Journal:  J Invest Dermatol       Date:  1982-10       Impact factor: 8.551

10.  Ultraviolet light depletes surface markers of Langerhans cells.

Authors:  W Aberer; G Schuler; G Stingl; H Hönigsmann; K Wolff
Journal:  J Invest Dermatol       Date:  1981-03       Impact factor: 8.551

View more
  4 in total

1.  Langerhans cell density and activity in mouse skin and lymph nodes affect herpes simplex type 1 (HSV-1) pathogenicity.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

2.  Role of Langerhans cells in epidermotropism of T cells.

Authors:  T Shiohara; N Moriya; K M Saizawa; M Nagashima
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

Review 3.  Role of Langerhans cells and other dendritic cells in viral diseases.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  Retinoic acid protects Langerhans' cells from the effects of the tumour promotor 12-O-tetradecanoylphorbol 13-acetate.

Authors:  G M Halliday; J L Dickinson; H K Muller
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.